Luca Boldrini

Radiation oncologist ☢️ clinical scientist 💡 Rome, Italy 🇮🇹

[SEOR.es @SEOR_ESP]

Sesión plenaria del #CONGRESOSEOR24 con @SEOR_ESP @ESTRO_RT @ALATRO_ #FARO @Mamen_RubioR @LCUBLD #SPRO

[Luca Boldrini @LCUBLD]

@airo_young @NutriOncRG @VSalvestrini @Atem84 @GrassiRoberta89 @FDeFelice_ @peppinoiorio @FMastroleoMD @isteddos @LilloCasa Young Italian RadOncs simply rock! 🧨

[youngAIRO @airo_young]

#NRG2024 meeting in Bologna 🇮🇹
Such a great event and what a wonderful #RadOncTeam ✌️✌️✌️ #AIROyoung @NutriOncRG

[Akila Viswanathan MD @ANViswanathanMD]

@ElsevierConnect is pleased to share from January's issue "Rectal Cancer MRI Guided Radiotherapy: A Practical Review for the Physician" by Dr. Giuditta Chiloiro, Dr. Gani @GI_RadOnc, and Dr. Boldrini @LCUBLD

https://t.co/3Ou0HTWend

[Stephen V Liu, MD @StephenVLiu]

Aggregate safety data for pembrolizumab monotherapy across trials in European Journal of Cancer with Dr. @JulieBrahmer et al (n=8937). G3+ AEs in 51% of pts, discontinuation from AE in 13%, fatal AEs 6%. Median time to immune-mediated AE was 85d.

https://t.co/isUwDQXEy3

[ESTRO @ESTRO_RT]

🌟Spotlight on online Adaptive RadioTherapy (ART) at the #ESTRO24 #RTT pre-meeting course. This course will provide the essential skills for safely practicing online #ART.
🔎 Explore the Scientific Programme: https://t.co/nPhJSdyHz3
⏳#ESTRO24 Early registration fee until 24 Jan.

[Andrea D'Aviero @AndreaDav89]

Today one of the peaks of my #radonc career, as one of my #rolemodels showed my akward face in one of his lecture.

Thanks @LCUBLD it’s an honour.

(Yes I need a professional headshot 😂😂😂)

#radonc #inspiration

[ESTRO @ESTRO_RT]

🗳️Election time coming up! We’re delighted to unveil the 2 candidates for ESTRO President: Barbara Jereczek-Fossa and Dirk Verellen.
📅 Voting opens on 19 February. ESTRO members will receive an email with some details tomorrow. Watch your mailbox!

[Luca Boldrini @LCUBLD]

Discussing and practice changing studies in #radonc with AIRO and @airo_giovani and friends…a few steps from the Colosseum!
💥 #radiotherapy #Science #cancer #ESTRO #ASTRO

[Luca Boldrini @LCUBLD]

The 10th MRinRT Symposium will take place at Fondazione Policlinico Universitario Agostino Gemelli IRCCS, in Rome, on 3-5 April 2024!

https://t.co/mI8tROTj72

⚡️Outstanding faculty and scientific programme
🧨 EB Registration 29 Feb
💣 Regular Registration 02 Apr

[Luca Boldrini @LCUBLD]

@Mat_Guc @ESTRO_RT @ASTRO_org @ISRSy @the_RSS I fully agree! It is one of our main duties as clinicians and scientists.
I had the chance to advocate for #radonc in Italy thanks to @AIRC_it !
DO NOT LEAVE RADIOTHERAPY BEHIND!

[Matthias Guckenberger @Mat_Guc]

Consequence to me:
👉 WE need to initiate and tell the stories about the benefits of modern Radiation Oncology as an important pillar of interdisciplinary cancer care
👉 we CANNOT expect others doing so
👉 we = all #radonc @ESTRO_RT @ASTRO_org @ISRSy @the_RSS …

[James Good @drjamesgood]

Without a quick and comprehensive resolution, the #MRIdian platform will disappear. Patients will miss out, and technical innovation in radiotherapy will be derailed. But we will not go quietly into that good night… read our open letter to the #radonc community👍

[Percy Lee, MD, MBA @PercyLeeMD]

(12/n) It is a stark reminder that even fundamentally paradigm shifting advances in technology may not overcome the technology chasm. I hope that is not true and humanity ultimately wins. In the meantime, see you again @viewray #MRIdian.

[Luca Boldrini @LCUBLD]

@airo_young @GrassiRoberta89 @FDeFelice_ @VSalvestrini @airo_young rocks

[Viola Salvestrini @VSalvestrini]

2023-24 board members of Italian young AIRO @airo_young 🇮🇹
Team effort💪🏻 #AIRO2023 @peppinoiorio @GrassiRoberta89

[VNardone @Valerio_Nardone]

Celebrating the incredible work of the @airo_young Steering Committee at #AIRO2023! 🙌 Their dedication and passion for advancing #radonc and motivating the new generation is truly inspiring. Hats off to this dynamic team! @VSalvestrini @peppinoiorio @GrassiRoberta89 @FDeFelice_

[Rai @Raiofficialnews]

"Nulla porta a un risultato subito. Noi ci sentiamo ingaggiati in una lotta complessa, perché il cancro è una malattia complessa, sia dal punto di vista biologico che sociale".
Luca Boldrini, Medico e ricercatore @AIRC_it presso il Policlinico Gemelli
#IGiorniDellaRicerca